Table 3.

Comparison of the severity indices at the day of tocilizumab administration of the propensity score matched cohort between the two arms to show the success of the matching

	Tocilizumab						P value1
	No			Yes
	n	Mean	SD	n	Mean	SD
On the day of admission
Age (years)	174	59.73	17.97	174	56.67	13.10	0.058
SpO2	162	91.24	7.10	171	90.79	6.96	0.053
Respiratory rate /min	159	23.08	5.08	145	23.95	7.79	0.86
Lymphocytes at admission	168	1.17	0.69	171	1.11	0.81	0.17
Neutrophils at admission	166	5.39	4.95	170	4.97	3.73	0.62
WBC at admission	168	7.21	5.15	158	6.13	4.02	0.048
On the day tocilizumab administration or similar days in the controls group
Procalcitonin (µg/L)	174	2.10	8.39	174	0.44	1.65	0.83
Neutrophils (103/mm3)	171	6.87	6.89	174	5.49	3.23	0.99
Lymphocytes (103/mm3)	171	0.93	0.61	174	0.98	0.90	0.63
d-dimer (mg/L)	152	3.34	4.82	152	2.84	2.78	0.53
Ferritin (µg/L)	174	819.46	605.32	174	1127.93	1294.91	0.11
CRP (mg/dl)	173	4.43	5.71	173	4.19	4.63	0.23

¹Wilcoxon–Mann–Whitney test